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Background:Dermalskinsubstituteshavebecomeastandardofcareinburntreatment.
Objective: To compare and assess wound contracture reduction and histologic incorpo-
rationintothewound,dermalsubstituteswereimplantedintofull-thicknessskinwounds
in nude mice. Materials and Methods: Thirty-seven mice received a full-thickness 2 ×
2c mdorsal skin wound, and were either implanted with an acellular dermal matrix, Al-
loderm, Dermagraft-TC, Dermalogen, or Integra or assigned to the control group (with
nodermalsubstitute).At28dayspostsurgery,thewoundswereassessedforcontraction,
epithelialization, and other histological characteristics. Results: Each dermal substitute
decreased wound contracture, but Alloderm and the acellular dermal matrix did so sig-
nificantly compared to the control (P< .01 and P< .03, respectively). Within-group and
control comparisons showed no significant differences with respect to the presence of
dystrophic calcification, squamous hyperplasia, infiltration of neutrophils, fibroblasts,
and macrophages, epidermal keratinocyte stratification, or collagen fiber configuration.
Conclusions: Integra elicited the greatest foreign body response. Although the Der-
malogen group had the thickest elastin fiber fragments, Dermagraft may have initiated
the earliest elastin fiber formation in the wounds. While all dermal substitutes were in-
corporated into the wound bed and wound contracture was decreased, acellular dermal
matrix and Alloderm, both human skin–derived products, produced less contraction and
the thickest new “dermis” in the healed wounds compared to the control or synthetic
dermal substitutes.
Early excision of the burn eschar has greatly improved burn patients’ survival. In
some cases, the patient is left with extensive regions devoid of dermis and poor cosmesis.
Currently, a variety of skin substitutes or artificial dermal replacements are used not only
to decrease morbidity and wound contracture in severely burned patients but also to en-
hance cosmesis of partial- and full-thickness burn wounds.1–9 Dermal substitutes serve as
a scaffold into which cells can migrate and repair the injury. Although dermal substitutes
and their histology have been described in the literature and several have been compared
to a split-thickness skin graft as the “criterion standard,” there have not been any studies
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comparing the efficacy of these dermal substitutes as a group in respect to wound contrac-
ture and histologic features. The purpose of this study was to compare the effectiveness of
several dermal substitutes in an animal model of wound healing. Human cadaver skin was
not used because it is viable rather than processed tissue. For this reason, acellular dermal
matrix (ADM) was a more compatible dermal substitute for this study because it was a
processed nonviable dermal substitute derived from human cadaver skin. We hypothesized
that human skin–derived dermal substitutes (ADM, Alloderm, and Dermalogen) would
generate a thicker dermis with less wound contraction than would control (Fibrin Sealant
Tisseel VH) or synthetic matrices (eg, Dermagraft-TC, Integra). The study compared the
wound healing attributes of various dermal substitutes grossly and histologically.
MATERIALS AND METHODS
Dermal matrices and ﬁbrin glue
ADM was prepared as described below and in the literature by Takami et al.10 It is a dermal
collagen matrix derived from banked human skin that is treated to remove all cellular
components.11
Alloderm (LifeCell Corporation, Branchburg, NJ) is a dermal collagen matrix derived
from banked human skin that is treated to remove most cellular components. It is freeze-
dried for shipping and storage.
Dermagraft-TC (Advanced Tissue Sciences, La Jolla, Calif) is composed of a woven
bioabsorbable polymer (polyglycolic and polylactic acids) membrane within which human
dermal fibroblasts are grown and then devitalized. It is used for reepithelialization of mid-
dermal and mid-to-deep–dermal indeterminate burn wounds and contains Type I collagen
fibers,glycosaminoglycans,andgrowthfactorssuchasTGF-betaanddecorin.Thisproduct
is not used as a dermal substitute in humans, although it was used as such in this study.
Dermalogen (Collagenesis, Beverly, Mass) is a powdered human dermal collagen
matrixthatistreatedtoremovesomecellularcomponents,isfreeze-dried,andisthenmilled
into a fine powder. The collagen concentration was mixed with RPMI (MP Biomedicals,
Inc, Aurora, Ohio) to form a 15 mg/mL solution. It is used primarily for aesthetic plastic
surgery, as a “filler.”
Integra (Integra Life Sciences Corporation, Plainsboro, NJ) is a bilayer artificial skin
replacement with a “dermal” layer composed of bovine collagen gel cross-linked with
shark chondroitin-6-sulfate. The synthetic “epidermal” layer is composed of a polysiloxane
polymer that was removed before use in this study.
Fibrin Sealant Tisseel VH (Baxter Health, Deerfield, Ill) is a 2-component fibrin glue
mixture:fibrinogen+calciumandthrombin+aprotinin(proteaseinhibitor)werecombined
quickly and dispensed onto a wound, forming a fibrin clot.
Preparation of ADM
Cryopreserved normal human skin (U.S. Tissue & Cell, Cincinnati, Ohio) obtained from
cadavers, using a dermatome set at 0.012 in thick, was thawed rapidly at 37◦C. It was
then treated with 2.5 units/mL Dispase II (Boehringer Mannheim, Indianapolis, Ind) in
phosphate-bufferedsalinecontaining0.2mMCaCl2at4◦Cfor24hourstoremoveepidermis
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and other cellular components from the dermal matrix. Subsequently, the dermal matrix
was incubated in buffered 0.5% Triton X-100 (United States Biochemical Corp, Cleveland,
Ohio) for 24 hours at room temperature with continuous shaking. ADM was extensively
washed with phosphate-buffered saline and stored in phosphate-buffered saline at 4◦C until
use. All solutions used for ADM preparation were filter-sterilized, and all procedures were
performed aseptically. Sodium azide (0.02% w/v) was present at all times in the extraction
solutions to prevent microbial growth, and was thoroughly washed out before implanting
the ADM.
Animals and surgery
Thirty-seven male NIH Swiss nude mice (NSWNU, homozygous, outbred, 4–5 weeks, 20–
25g)wereused.ThestudywasreviewedandapprovedbytheInstitutionalAnimalCareand
Use Committee. Animals were housed in sterilized cages with sterile feed, water, and bed-
ding.Asingledoseofantibiotic(kanamycin;25units/kg)wasadministeredintramuscularly
to all animals approximately 1 hour prior to surgery. All survival surgery was performed
using aseptic technique in the Animal Facility operating rooms. Anesthesia consisted of
ketamine/xylazine (150/8 mg/kg) administered intraperitoneally with additional ketamine
(30mg/kg)givenintraperitoneallyasneededtomaintaindeepanesthesia.Standardizedfull-
thickness 20 mm × 20 mm skin wounds (removing the panniculus carnosus muscle layer)
were excised from the dorsum of each anesthetized mouse. On Day 0, the mice weighed
(mean ± SD) 27 ± 3gand on Day 28, they weighed 31 ± 2g ,showing an overall weight
gain of 4.6 ± 2g .Mice with the Alloderm implant gained the most weight (6.5 ± 2g )
compared to the other groups. The weight gain included the weight of the implanted dermal
substitute, which was not weighed at the time of implantation.
Implantation of dermal substitutes
There were 6 study groups: ADM, Alloderm, Dermagraft-TC, Integra, Dermalogen, and
control. The control group had the same type of wound and wound treatment as the other
groups but did not receive a dermal substitute. Dermalogen solution (0.75 cc) was placed
into the wound; skin at the wound corners was sutured to the underlying muscle. Each of
the dermal matrices was cut to the size of the wound and sutured to the adjoining skin and
the underlying muscle at their corners using nylon suture. The Integra silicone layer was
removed after the Integra gel was placed into the wound. Fibrin Sealant Tisseel VH was
sprayed on the wounds, which were then covered with semipermeable adhesive film (Op-
Site, Smith and Nephew, Largo, Fla), Xeroform (Sherwood Medical, St. Louis, Mo), and
dry cotton gauze. This dressed wound was then covered with fine stainless steel mesh fixed
onto the animal’s back with 4 sutures to the skin, each about 1 cm distant from the wound.
The mesh was used to prevent the wounds from being disturbed by chewing or scratching.
Animals and wounds were inspected daily to ensure that the dressings were intact. After 2
to 3 weeks postsurgery, the wounds were partially healed and the stainless steel mesh was
removed.Attheendofthe4-weekstudyperiod,allanimalswereeuthanizedandthewounds
were harvested, fixed in 10% buffered formalin, cut into five to seven 2-mm sections, and
prepared for histological analysis.
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Gross and histologic measurements and assessments
Wound characteristics were measured grossly as well as histologically on Day 28 post-
surgery. Direct measurements of wound area and the extent (area) of epithelialization
and wound contraction were determined from digital photographs (Olympus C3030) us-
ing computer planimetry software (UTHSCSA ImageTool for Windows v. 2.00). All
excised healed wounds were paraffin-embedded, and sections were stained with Hema-
toxylin & Eosin, Masson Trichrome, and Elastin Van Gieson. A “blinded” patholo-
gist (A.K.V .) evaluated all samples histologically for depth and length of the healed
wound area, epithelial stratification, incorporation of the dermal substitute, degree of
neutrophil, macrophage, fibroblast, and foreign body giant (FBG) cell infiltration, and
extent of elastin formation. This examination was performed using an Olympus mi-
croscope with a millimeter ruler eyepiece adapter. Histologic assessment was per-
formed in low-power fields (100× magnification) on all cross sections of each wound
area.
Statistical analysis
Study groups were compared utilizing Statistica (Statsoft, Tulsa, Okla). Summary descrip-
tive statistics such as median, means, standard deviation and error, 1-way analysis of vari-
ance, chi-square 2 × 2 summary frequencies (Pearson and Maximum Likelihood), and
the Tukey test for unequal numbers were calculated. Nonparametric analyses utilized the
Kruskal-Wallis analysis of variance by Ranks and Mann-Whitney U test. A P value of less
than .05 was considered significant.
RESULTS
Wound contracture
Table1shows the dimensions of the healed wounds at 28 days postsurgery for each group.
Dermal substitute implantations and control decreased wound contraction when as-
sessedbypercentageretentionoftheoriginalwoundarea:Controlby34%±7%;Dermalo-
gen by 39% ± 9%; Integra by 46% ± 12%; Dermagraft-TC by 50% ± 22%. Based on the
initial 400 mm2 wound surface area, Alloderm and ADM underwent the least contracture
andretainedthegreatestmeansurfaceareacomparedtocontrolandotherdermalsubstitutes
(63% ± 14% [P< .01] and 57% ± 7% [P< .03) total wound surface area, respectively),
Figure 1.
Epithelialization
Gross and histologic evaluation of surface epithelialization correlated well; wounds were
80%to99%epithelializedasdeterminedbybothmethods.Ofinterest,Dermagraft-TCwas
fully incorporated as a neodermis in this mouse model even though it is not used in this
manner in human burn patients. The length and depth of the healed wound were evaluated
histologically(Fig2).ADMproducedasignificantlythicker(P<.04)neodermiscompared
to the control.
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Table 1. Dimensions of healed wounds treated with dermal substitutes at 28 days postsurgery:
gross and histologic evaluations
Acellular
dermal Dermagraft-
Parameters Control Integra Alloderm matrix TC Dermalogen
# Cases 7 6 6 6 5 6
%T otal surface wound∗ 34 ± 7† 46 ± 12 63 ± 14† 57 ± 7† 50 ± 22 39 ± 9
% Surface epithelialization∗ 100 ± 19 2 ± 78 6 ± 98 7 ± 10 82 ± 10 95 ± 8
Surface wound length, mm‡ 5 ± 27 ± 29 ± 61 0 ± 28 ± 37 ± 2
Under surface wound length, 6 ± 28 ± 21 2 ± 31 2 ± 19 ± 39 ± 3
mm‡,§
Neodermis depth, mm‡ 0.7 ± 0.1 1.3 ± 0.6 0.95 ± 0.5 1.4 ± 0.3 0.8 ± 0.24 1.0 ± 0.3
∗Gross measurement based ona4c m 2 wound area.
†P <. 03 compared to control.
‡Histologic microscopic measurement.
§Two-dimensional length beneath the epidermal layer without the presence of hair follicles and adnexa.
Mouse keratinocytes migrated inward from the wound margins to regenerate the epi-
dermis. The normal uniform 4-cell layer thick epidermis was replicated in control and
Alloderm groups, but Integra, Dermagraft-TC, and Dermalogen groups exhibited a sig-
nificantly thicker epidermal layer than did the control group, P< .04. Integra, Alloderm,
and Dermagraft-TC groups showed a highly variable number of cell layers (1–5) in the
epidermis (Fig 3).
Neodermis
The healing process was characterized by mouse macrophages and fibroblasts initiating
the repair and deposition of new fibrous tissue above and below the dermal substitutes
envelopingthemunderanepidermallayer.Newbloodvesselsandcapillarieswereobserved
Figure 1. Size of the 28-day wound as a percentage of
the original wound surface area. ADM indicates acellular
dermal matrix.
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Figure 2. Healed wound dimensions (depth and length his-
tologically) at 28 days postsurgery. ADM indicates acellular
dermal matrix.
within the dermal substitutes and the new fibrous tissue beneath the dermal substitutes.
Histologically, the healed wound area was well delineated due to the lack of hair follicles
and adnexa, which remained at and outside the healed wound margins. Because the dermal
substitutesextendedlaterallytoagreaterextentthanvisualizedgrossly,themicroscopically
Figure 3. Cross sections of wounds showing epidermal regeneration over dermal
substitutes. ADM indicates acellular dermal matrix.
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Table 2. Histologic characteristics of the 28-day postsurgery healed wound area∗,†
Acellular
dermal Dermagraft-
Parameters Control Integra Alloderm matrix TC Dermalogen
# Cases 7 6 6 6 5 6
% Squamous hyperplasia 14 67 33 17 40 67
% Squamous pearls 71 83 50 0 40 17
% FBG cells 0 100 0 33 0 17
% Dystrophic calcification 0 17 0 0 20 17
∗Percentages reflect the frequency of histologic features within each study group.
†FBG indicates foreign body giant.
recorded healed wound lengths were increased in all groups; ADM and Alloderm groups
maintained the original wound dimensions after healing, with the least contracture of the
wound surface area (Table 1).
Miscellaneous
The histologic characteristics of 28-day wounds are shown in Table 2.
TheIntegramatrixwasencasedinfibroustissuewithasignificantlygreaternumberof
FBG cells compared to the control group and the other study groups, P< .003. Squamous
hyperplasia, a reactive florid overgrowth of the epidermal layer, was seen most frequently
with Integra, Dermagraft-TC, and Dermalogen. Squamous pearls (a result of keratinocyte
degeneration) were prominent in Integra (83%) and control (71%) groups, followed by
Alloderm (50%), Dermagraft-TC (40%), and Dermalogen (22%) groups but were absent
from the ADM group (P< .04). By Day 28, Integra and Dermagraft-TC (dermal substi-
tutes with the least resemblance to human dermis) were not incorporated into the fibrous
dermal network and granulation tissue as well as were Alloderm, Dermalogen, and ADM.
Histologically, the Integra framework and Dermagraft-TC polymers and membrane were
still evident, not resorbed, although the wounds were healed. Within-group and control
comparisons showed no significant differences with respect to the presence of dystrophic
calcification, squamous hyperplasia, extent of granulation tissue, numbers of infiltrating
neutrophils, fibroblasts, and macrophages, epidermal keratinocyte stratification, or colla-
gen fiber configuration.
Integra
In contrast to the other dermal substitutes used here, Integra showed the least propensity for
a fibrous dermal restructuring by Day 28; squamous pearls filled the crevices of the Integra
“scaffold,” and the hyalinized interstitium was extensively infiltrated by FBG cells. In the
healed wound, the Integra matrix was enveloped by fibrous tissue with “islands” of Integra
isolated by the ingrowth of fibers into areas that had been cleared by FBG cells. This was
a morphology unlike that seen with any of the other dermal substitutes. Horizontal fibers,
bothsuperficialanddeep,arrayedparalleltothetissueinterfacessurroundedandinfiltrated
the other dermal substitutes in the healed wound areas.
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Elastin
The newly formed fibrous tissue in all groups contained few elastin fibers. Some of the
dermal substitutes contained intrinsic elastin fibers in varying quantities. There were no
elastin fibers seen in the control or Integra group, but fibers were prominent in wounds
implantedwithDermalogenasshort,stubbythickstrands.Theywerealsopresenttovarying
degrees in wounds implanted with Dermagraft-TC, Alloderm, and ADM. Slim threads that
stained with the Elastin Van Gieson stain were seen in the newly formed fibrous tissue
enveloping the Dermagraft-TC–implanted healed wound area. To a lesser degree, ADM
and Dermalogen groups showed elastin strands that may have been displaced in the healing
processintothenewlygeneratedfibroustissuearoundtheperipheryoftheimplanteddermal
substitute.
DISCUSSION
Wound contracture
All full-thickness wounds implanted with/without dermal substitutes produced epithelial-
ized healed wounds without dermal appendages by Day 28 postsurgery. The dermal substi-
tuteswereincorporatedintothehealedwoundstoagreaterorlesserextentdependingonthe
initial composition of the substitute. Although there was histologic variability in the com-
position of the healed wounds, all dermal interventions decreased wound contraction and
supported the formation of an epidermis. ADM and Alloderm, both human skin–derived
materials,showedlesscontractioninthehealedwoundscomparedtothecontrolorthenon-
human skin–derived dermal substitutes. Dermalogen, while replete with fragmented elastic
fibers, remained amorphous during healing and expanded along the wound margins, result-
ing in a thinner healed dermis. The control, which had only Fibrin Sealant on the wound
surface, also decreased wound contracture by retaining 30% of the original wound area.
The use of fibrin glue as a “dermal substitute” had been previously described.12Although it
decreased wound contracture in this study, Fibrin Sealant was not as effective as the other
dermal substitutes in creating a substantial neodermis.
Epithelialization
All wounds implanted with dermal substitutes were epithelialized. Integra and ADM re-
quire iatrogenic intervention in patients (eg, for skin grafting), but in this model, compe-
tent mouse-derived epidermal layers (although thin) formed over the matrix without the
need for additional skin grafting. Reports in the literature indicate that adult mouse bone
marrow cells can differentiate into all skin components such as epidermal keratinocytes,
sebaceous gland cells, and epithelial, dendritic, and endothelial cells.13 It is unknown at
this time whether the epidermal layer expanded from the epidermis along the wound mar-
gin or formed from adult mouse bone marrow cells that populated the area. Dermalogen
and Integra showed a propensity for squamous hyperplasia, an exuberant regeneration of
the epidermal layer. Human burn scars may develop pseudoepitheliomatous hyperplasia
(disordered progression of squamous hyperplasia), with a proclivity toward aneuploidy,
which may predispose toward the development of squamous cell carcinoma.14 The present
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study showed that while squamous hyperplasia was seen, all wounds healed without evi-
denceofmalignantprogression.Currentliteraturereportinglong-termfollow-upofpatients
who received these dermal substitutes has shown no tendency toward the development of
malignancy.
Neodermis
Successful treatment with dermal skin substitutes requires low antigenicity, the capacity
for rapid vascularization, and stability as a dermal template.7–9 Dermal substitutes provide
stability to split-thickness skin grafts and to cultured epithelial autografts. In this study, the
dermal substitutes may have formed a barrier that prevented hair follicle and skin adnexa
reconstitution within the 28-day study period. The most acceptable dermal substitutes were
derivedfromfull-orsplit-thicknessallogeneicskintreatedtoremoveepithelialcomponents
(keratinocytes, sweat glands, and sebaceous glands) and dermal components (fibroblasts,
vascular endothelium, and smooth muscle) compared to those derived from xenogenic
materials (pig or bovine skin, shark cartilage, etc). “Scaffolding” in ADM and Alloderm
consisted of already well-formed fibrous tissue. In contrast, Integra required a dissolution
of its “foreign body scaffolding” before the more permanent fibrous tissue could be laid
out in the area it occupied. The human skin–derived dermal substitutes provided a thicker
and longer dermis because they had, albeit altered, greater mass to start with in terms
of collagen, and other fibers into which the macrophages and fibroblasts could infiltrate,
initiating angiogenesis and dermal substitute incorporation.
Integra
It has been previously reported that 14.4% of human patients who received Integra de-
veloped the FBG cells and eosinophils.15 The present study showed numerous FBG cells
in the Integra-implanted healed wound. This was probably a reaction to the constituents
(ie, denatured bovine collagen and shark chondroitin sulfate) of Integra, which were per-
ceived as foreign bodies. It is possible that this process contributed to the thinner “new
dermis” observed here with Integra and it deserves further investigation, especially at later
postsurgical intervals. This foreign body reaction to Integra components in some patients
may be impacting the generation and vascularization of the new dermis as the wound
heals.
Elastin
Althoughittakesyearsforelastinfiberstobecomeestablishedinhumanscars,elastinfibers
may form as early as 90 days into the wound healing process in mice.16 While elastin has a
complex structure, there have been reports of earlier elastin deposition, as early as 40 days
after grafting in humans.16–19 Dermagraft-TC when used as a dermal substitute appeared
to promote the formation of elastin fibers earlier than did other dermal substitutes. Further
study is needed to determine whether the elastin fibers were newly formed or whether they
were transposed or redistributed from the dermal substitute during the progression of the
fibrous network repair.
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Potential areas of investigations
Thisstudy,whileshowingthatthehumanskin–deriveddermalmatricesformedthethickest
neodermis and produced the least amount of contracture, was a relatively small study that
investigated wound healing during a limited time period. Epithelialized wounds remodel
continually for more than a year. Several questions were raised in this study that merit
continued comparison of dermal substitutes and their long-term effects on wound healing.
It is unknown whether the characteristics of each dermal substitute, observed at 28 days,
would have been sustained for longer time intervals. Do patients receiving Integra as a
dermal substitute retain the same skin pliability several years later? Why do some dermal
substituteselicitaFBGcellreactionandothersdonot?HoweffectiveisFibrinSealantalone
as a dermal substitute? Do these dermal substitutes perform differently in burn/excised
wounds? Investigations are underway to assess these questions, and to determine the long-
term sequelae and wound remodeling characteristics of these dermal substitutes.
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